(Bai zhu), delays liver fibrosis progression by inhibiting the release of hepatic fibrosis-associated genes and reducing periportal collagen deposition by inhibiting the PI3K/Akt pathway and glutamine metabolism [56]. This evidence concerns the gene AKT1 and Hepatic fibrosis.